CytomX Therapeutics Inc. (CTMX)
0.65
-0.03 (-4.02%)
At close: Mar 03, 2025, 3:59 PM
0.65
0.12%
After-hours: Mar 03, 2025, 04:06 PM EST
CytomX Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -569K | -99.32M | -83.61M | -32.88M | -102.24M | -84.6M | -43.1M | -58.9M | -35.37M | -30.31M | -15.14M |
| Depreciation & Amortization | 2.17M | 2.44M | 2.71M | 2.57M | 2.6M | 1.88M | 1.65M | 1.73M | 1.21M | 783K | 655K |
| Stock-Based Compensation | 8.56M | 13.13M | 13.17M | 14.79M | 19.1M | 16.88M | 11.29M | 10.1M | 3.99M | 553K | 343K |
| Other Working Capital | -93.64M | 4.47M | -66.21M | 30.89M | -47.74M | -38.2M | 189.91M | 43.32M | -6.13M | 61.46M | 5.5M |
| Other Non-Cash Items | -3.69M | 3.62M | 3.13M | 2.89M | 1.6M | -1.7M | 11.09M | 1.77M | 3.01M | 95K | 169K |
| Deferred Income Tax | n/a | n/a | 272K | -236K | -2.23M | n/a | -513K | 6K | 8K | 8K | 10K |
| Change in Working Capital | -62.51M | -30.65M | -54.7M | 18.13M | -59.32M | -7.98M | 189.97M | 43.26M | -248K | 60.67M | 5.96M |
| Operating Cash Flow | -56.03M | -110.79M | -119.03M | 5.26M | -140.48M | -75.52M | 170.37M | -2.03M | -27.41M | 31.8M | -8.01M |
| Capital Expenditures | -840K | -1.74M | -1.61M | -2.31M | -3.5M | -3.79M | -1.56M | -2.18M | -1.59M | -1.66M | -732K |
| Acquisitions | n/a | n/a | -24.1M | 16.41M | -83.2M | -5.93M | 121.27M | 52K | n/a | n/a | n/a |
| Purchase of Investments | -424.83M | n/a | -99.9M | -199.11M | -174.99M | -204.6M | -218.71M | -121.52M | -250.9M | n/a | n/a |
| Sales Maturities Of Investments | 275M | 100M | 124M | 182.7M | 258.19M | 214.31M | 99M | 169.5M | 122.75M | n/a | n/a |
| Other Investing Acitivies | n/a | 100M | 24.1M | -16.41M | 83.2M | 5.93M | -121.27M | 52K | -817K | n/a | n/a |
| Investing Cash Flow | -150.67M | 98.26M | 22.49M | -18.72M | 79.7M | 5.93M | -121.27M | 45.86M | -130.56M | -1.66M | -732K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 78K | -3.07M | -1.26M | 2.63M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.71M | n/a | n/a |
| Other Financial Acitivies | 30.23M | 648K | 2.5M | 5.61M | 1.63M | 5.03M | 3.84M | 918K | 81.4M | 26.81M | 62K |
| Financial Cash Flow | 30.23M | 648K | 110.21M | 16.89M | 1.63M | 139.62M | 23.8M | 996K | 153.4M | 25.55M | 2.7M |
| Net Cash Flow | -176.48M | -11.88M | 13.67M | 3.43M | -59.15M | 70.03M | 72.9M | 44.82M | -4.57M | 55.69M | -6.04M |
| Free Cash Flow | -56.88M | -112.53M | -120.64M | 2.95M | -143.98M | -79.31M | 168.81M | -4.21M | -29.01M | 30.14M | -8.74M |